Ganoderma lucidum (Curtis) P. Karst. Immunomodulatory Protein Has the Potential to Improve the Prognosis of Breast Cancer Through the Regulation of Key Prognosis-Related Genes.

Ganoderma lucidum

OncologyImmune supportMetabolic healthLiver support

SpeciesReishi, Lingzhi

JournalPharmaceuticals (Basel, Switzerland)

Year2024

Metadata-grounded summary

Article summary

Metadata-grounded summary: This research article indexes research on Ganoderma lucidum in Pharmaceuticals (Basel, Switzerland) in 2024. MycoData maps the paper to oncology, immune support, metabolic health, liver support based on its title, species context, article metadata, and study classification.

Citation

Zuo Z, Wen R, Jing S, Chen X, Liu R, Xue J, et al. (2024). Ganoderma lucidum (Curtis) P. Karst. Immunomodulatory Protein Has the Potential to Improve the Prognosis of Breast Cancer Through the Regulation of Key Prognosis-Related Genes. Pharmaceuticals (Basel, Switzerland) https://doi.org/10.3390/ph17121695 PMID: 39770537

Open citation